A
Achilles Therapeutics PLC
NASDAQ:ACHL
Achilles Therapeutics PLC
NASDAQ:ACHL
Price:
1.48
USD
0.68%
Market Cap:
$60.8m
Balance Sheet
Balance Sheet Decomposition
Achilles Therapeutics PLC
Achilles Therapeutics PLC
Balance Sheet Decomposition is not available for
Achilles Therapeutics PLC
Achilles Therapeutics PLC
Balance Sheet
Achilles Therapeutics PLC
Achilles Therapeutics PLC
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
11
|
98
|
178
|
266
|
173
|
132
|
|
| Cash Equivalents |
11
|
98
|
178
|
266
|
173
|
132
|
|
| Total Receivables |
0
|
0
|
1
|
1
|
1
|
1
|
|
| Other Current Assets |
3
|
5
|
9
|
18
|
23
|
13
|
|
| Total Current Assets |
13
|
103
|
188
|
285
|
197
|
146
|
|
| PP&E Net |
1
|
2
|
28
|
29
|
21
|
14
|
|
| PP&E Gross |
1
|
2
|
28
|
29
|
21
|
14
|
|
| Accumulated Depreciation |
0
|
1
|
1
|
5
|
8
|
13
|
|
| Other Long-Term Assets |
0
|
0
|
3
|
4
|
3
|
2
|
|
| Total Assets |
14
N/A
|
105
+651%
|
219
+108%
|
317
+45%
|
220
-30%
|
161
-27%
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
1
|
6
|
4
|
5
|
6
|
|
| Accrued Liabilities |
1
|
2
|
9
|
14
|
11
|
11
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
1
|
1
|
2
|
1
|
|
| Total Current Liabilities |
1
|
4
|
17
|
19
|
18
|
17
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
13
|
9
|
5
|
2
|
|
| Total Liabilities |
1
N/A
|
4
+200%
|
30
+656%
|
28
-6%
|
23
-16%
|
19
-18%
|
|
| Equity | |||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
11
|
25
|
58
|
119
|
190
|
260
|
|
| Additional Paid In Capital |
24
|
118
|
235
|
402
|
409
|
415
|
|
| Other Equity |
0
|
8
|
12
|
7
|
22
|
13
|
|
| Total Equity |
13
N/A
|
101
+698%
|
189
+87%
|
290
+53%
|
197
-32%
|
142
-28%
|
|
| Total Liabilities & Equity |
14
N/A
|
105
+651%
|
219
+108%
|
317
+45%
|
220
-30%
|
161
-27%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
41
|
41
|
41
|
41
|
41
|
41
|
|
Switch to:
Switch to:
See Also
Discover More
